{"title":"Helicobacter pylori Infection and Thoracic Aortic Aneurysm: Insights from Mendelian randomization.","authors":"Cheng-Zhi Zhang, Can-Ran Lv, Zhuo-Hang Cui, Jiao-Jiao Wang, Jing Zhang, Jian Yang","doi":"10.1016/j.jjcc.2025.05.001","DOIUrl":null,"url":null,"abstract":"<p><p>The association between Helicobacter pylori (H. pylori) infection and the development of thoracic aortic aneurysm (TAA) remains inconclusive. Globally, approximately 58% of the population is infected with Helicobacter pylori. It is typically associated with chronic gastritis, peptic ulcers, and gastric cancer1. Mendall et al. were the first to report a serological correlation between H. pylori seropositivity and coronary heart disease2, a finding that has gradually spurred interest in the potential role of the bacterium in the pathogenesis of cardiovascular diseases. Previous studies have demonstrated an association between H. pylori-specific serotypes and acute ascending aortic dissection, particularly highlighting the chronic infection with the CagA-VacA s1m1 subtype, which is closely linked to an increased risk of aortic rupture3. Recent studies have suggested that the eradication of H. pylori is associated with a reduced incidence of abdominal aortic aneurysm in patients with peptic ulcer disease4. However, the causal relationship between H. pylori seropositivity and TAA remains unclear. In this study, we employed Mendelian randomization (MR) analysis to explore the potential causal link between H. pylori infection and TAA with the aim of providing further evidence supporting their association.</p>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jjcc.2025.05.001","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
The association between Helicobacter pylori (H. pylori) infection and the development of thoracic aortic aneurysm (TAA) remains inconclusive. Globally, approximately 58% of the population is infected with Helicobacter pylori. It is typically associated with chronic gastritis, peptic ulcers, and gastric cancer1. Mendall et al. were the first to report a serological correlation between H. pylori seropositivity and coronary heart disease2, a finding that has gradually spurred interest in the potential role of the bacterium in the pathogenesis of cardiovascular diseases. Previous studies have demonstrated an association between H. pylori-specific serotypes and acute ascending aortic dissection, particularly highlighting the chronic infection with the CagA-VacA s1m1 subtype, which is closely linked to an increased risk of aortic rupture3. Recent studies have suggested that the eradication of H. pylori is associated with a reduced incidence of abdominal aortic aneurysm in patients with peptic ulcer disease4. However, the causal relationship between H. pylori seropositivity and TAA remains unclear. In this study, we employed Mendelian randomization (MR) analysis to explore the potential causal link between H. pylori infection and TAA with the aim of providing further evidence supporting their association.
期刊介绍:
The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.